Article
Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients.
Modern rheumatology - 1 Jul 2015
Başaran Özge, Uncu Nermin, Çelikel Banu Acar, Taktak Aysel, Gür Gökçe, Cakar Nilgun
Abstract excerpt
OBJECTIVES: The aim of this report was to evaluate and discuss treatment of pediatric familial Mediterranean fever (FMF) patients with anti-interleukin1 (IL-1) agents. METHODS: Refractory or colchicine unresponsive FMF was described as severe and frequent attacks and/or having high acute phase reactance levels despite having a maximum dose of colchicine (2 mg/day). Disease course, adverse effects, duration of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
